| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/11/2002 | CN1368511A Human protein with cancer inhibiting function and its coding sequence |
| 09/11/2002 | CN1368510A Human protein with suppression to cancer cell growth and its coding sequence |
| 09/11/2002 | CN1368509A Human protein with suppression to cancer cell growth and its coding sequence |
| 09/11/2002 | CN1368384A Genetically engineered vaccine of MUC-1 antigen for human breast cancer |
| 09/11/2002 | CN1368293A Nano monkshood rhizome medicine and its preparing process |
| 09/11/2002 | CN1368268A Nano medicine 'Brucea fruit oil' and its preparing process |
| 09/11/2002 | CN1368258A Nano medicine 'Zhongjiefeng' and its preparing process |
| 09/11/2002 | CN1368173A Tonglinxiaozheng Particles for treating carcinoma of urinary bladder and its preparing process |
| 09/11/2002 | CN1368172A Qibeifeian particles for treating cancer of lung and its preparing process |
| 09/11/2002 | CN1368168A Nano medicine 'Fenghuangtai' and its preparing process |
| 09/11/2002 | CN1368113A Nano Medicine 'Xuezaisheng' and its preparing process |
| 09/11/2002 | CN1368108A Nano medicine 'Shengxue Tiaoyuan' and its preparing process |
| 09/11/2002 | CN1368050A Process for preparing VE-succinate injection |
| 09/11/2002 | CN1090634C Pro-drugs and counterparts of camptothecin, their application as medicines |
| 09/11/2002 | CN1090632C Intermediates for preparation of duocarmycin SA and derivatives thereof, and process for production of intermdiates |
| 09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 09/11/2002 | CN1090506C Application of lysozyme dimer |
| 09/11/2002 | CN1090505C 多功能酶 Multifunctional enzyme |
| 09/11/2002 | CN1090501C Chinese drugs for treating carcinosis |
| 09/11/2002 | CN1090494C Medicine for treating aplastic anemia acute granulocytic leukemia and chronic granulocytic leukemia |
| 09/11/2002 | CN1090487C Pharmaceuticals for treating and preventing cancer and its prepn. art |
| 09/11/2002 | CN1090486C Chinese patent medicine for treating cancer metastasis |
| 09/10/2002 | WO2001070756A2 Lipopolysaccharides (lps) extracted from escherichia coli |
| 09/10/2002 | US6448429 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates |
| 09/10/2002 | US6448379 Inhibitors to il8 receptor binding, including antibodies, that interact with the amino-terminal extracellular domain of the il8 receptor and compete with il8 and other related natural ligands, for receptor-binding. |
| 09/10/2002 | US6448376 Two new proteins which appear to be new members of the e2f gene family, called e2f-5 |
| 09/10/2002 | US6448288 Cannabinoid drugs |
| 09/10/2002 | US6448287 Enhanced efficacy of sodium ascorbate against three dimensional in vitro tumors and in mouse tumors; safe |
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448285 Disorders associated with overactivity of 5 alpha reductase; androgen dependent disorders such as seborrhoea, acne, hirsutism and/or androgenic alopecia |
| 09/10/2002 | US6448277 VEGF receptor tyrosine kinase inhibitors |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448272 Myt1 kinase inhibitors |
| 09/10/2002 | US6448271 Substituted benzimidazoles and their use as parp inhibitors |
| 09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
| 09/10/2002 | US6448253 Adenosine A3 receptor modulators |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/10/2002 | US6448239 Porphyrin ring metallic complexes that are effective peroxynitrite decomposition catalysts for treatment of diseases involving the accumulation of this oxidant, such as altzeimer's disease |
| 09/10/2002 | US6448230 Testis expressed polypeptide |
| 09/10/2002 | US6448083 Contacting a mammalian cell with filamentous phage particles presenting a ligand on their surfaces, wherein a vector within the phage encodes a gene product under control of a promoter |
| 09/10/2002 | US6448078 Inhibiting human vpr interacting protein activity in a cell using a nucletide sequence complementary to a portion of the nucleotide sequence that encodes hvip; anticancer agent |
| 09/10/2002 | US6448074 Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells |
| 09/10/2002 | US6448073 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6447810 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar, water; improvement in disease resistance, weight gain rate, crop yield, crop quality, harvest time; antibody production and immune enhancement |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447780 Administering heat shock proteins (hsp) complexed with antigens; antigrowth agents or development inhibitors for cancer; immunology; vaccines |
| 09/10/2002 | US6447776 Monoclonal antibodies against mutant amino acid sequences generated by genetic deletions or point mutations; detection of cancer |
| 09/10/2002 | US6447769 Modified tumor cells to inhibit transforming growth factor |
| 09/10/2002 | US6447748 Benzamide compounds for cancer imaging and therapy |
| 09/10/2002 | CA2402544A1 Lipopolysaccharides (lps) extracted from escherichia coli |
| 09/10/2002 | CA2163218C New macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions |
| 09/10/2002 | CA2132449C 17 - substituted steroids useful in cancer treatment |
| 09/08/2002 | CA2370324A1 Large circular target-specific antisense nucleic acid compounds |
| 09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | WO2002068653A2 Tri-hybrid melanoma antigen |
| 09/06/2002 | WO2002068635A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 09/06/2002 | WO2002068630A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | WO2002068627A2 Vector constucts |
| 09/06/2002 | WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | WO2002068615A2 Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives |
| 09/06/2002 | WO2002068614A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | WO2002068585A2 Tip39 polypeptides |
| 09/06/2002 | WO2002068548A1 Use of erss-selective ligands for regulating fertility and compounds useful therefore |
| 09/06/2002 | WO2002068477A1 Highly sulfated derivatives of k5 polysaccharide and their preparation |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068461A2 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | WO2002068457A2 Antiangiogenic peptides derived from endostatin |
| 09/06/2002 | WO2002068455A2 Efficient recovery of correctly refolded proteins |
| 09/06/2002 | WO2002068444A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 09/06/2002 | WO2002068427A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 09/06/2002 | WO2002068425A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
| 09/06/2002 | WO2002068424A1 Indole derivatives having an inhibitory effect on protein kinases |
| 09/06/2002 | WO2002068421A2 Tricyclic compounds and their analogs as inhibitors of cytokine signaling |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068414A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 09/06/2002 | WO2002068412A1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment |
| 09/06/2002 | WO2002068411A1 Cdk-1 inhibitor oxindoles and the application thereof in therapeutics |
| 09/06/2002 | WO2002068410A1 Substituted pyrimidinone derivatives as ligands of integrin receptors |
| 09/06/2002 | WO2002068408A1 Chemical derivatives and the use thereof as an anti-elomerase agent |
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | WO2002068395A1 Hiv inhibiting n-aminoimidazole derivatives |
| 09/06/2002 | WO2002068390A1 Diamides which inhibit tryptase and factor xa activity |
| 09/06/2002 | WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002068381A2 Aryl-n-cyanoguanidines and methods related thereto |
| 09/06/2002 | WO2002068379A2 Novel bifunctional chelating compounds containing hydroxamic acid residues |
| 09/06/2002 | WO2002068015A2 Modular infusion device and method |
| 09/06/2002 | WO2002067999A2 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 09/06/2002 | WO2002067998A2 Devices and methods for the treatment of cancer |
| 09/06/2002 | WO2002067990A1 Polynucleotide formulation for enhanced intracellular transfer |
| 09/06/2002 | WO2002067986A2 Symbiotic regenerative agent |
| 09/06/2002 | WO2002067975A1 Negative regulation of epidermal growth factor receptor activity by mig-6 |
| 09/06/2002 | WO2002067974A1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 09/06/2002 | WO2002067971A2 Use of endostatin in the treatment of ocular neovascularization |
| 09/06/2002 | WO2002067968A2 14-3-3 binding molecules as sensitizers for anticancer therapies |
| 09/06/2002 | WO2002067964A1 Compositions and methods for cancer prevention and treatment derived from $i(inula britannica) |
| 09/06/2002 | WO2002067962A1 The method for preparating an anemone raddeana extract and the pharmaceutical composition containing the same as well as use thereof |
| 09/06/2002 | WO2002067961A2 Therapeutic uses of herbal compositions |